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Abstract
An estimated 6 to 10% of myocardial infarctions occur in patients under the age of 45. Usually
this applies to men, but an increasing prevalence is being observed among women. Atheroscle-
rosis, often one vessel disease, is the main cause. The presence of classic risk factors affects the
dynamics of coronary artery disease: the strongest risk factor is smoking, regardless of gender.
Environmental influence is also possible. No atherosclerosis is found in 20% of young pa-
tients. In such cases, the most frequent mechanisms of ischemia are: coronary artery embolism
(5%), thrombosis (5%), anomalies (4%) and inflammation or spasm of the vessel. Age is an
independent prognostic factor. Thus the clinical outcome after myocardial infarction is better
in younger than in older patients. (Cardiol J 2009; 16, 4: 307–311)
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It is 60 years since the publication of Yater’s
study of myocardial infarctions (MI) in 866 young
war invalids [1]. Since then, there have been many
studies regarding myocardial infarctions in young
people. The borderline differentiating younger from
older patients is the age of 40. However, many au-
thors treat cases of MI in individuals under the age
of 45 as being MI in the young.
Myocardial infarctions in patients below the
age of 40 constitute about 10% of all cases [2]. The
majority of sufferers are men, but an increasing
prevalence among women has been observed; now-
adays one in four patients with MI younger than
45 years are women [3].
Epidemiological studies conducted in Poland
(POL-MONICA 1994, NATPOL PLUS 2002,
WOBASZ 2005) indicate a decrease in mortality
from cardiovascular diseases.  Nevertheless, in
western Europe these mortality indexes (standard-
ised to age) are 2.5 times lower than in Poland [4].
This explains the importance of cardiovascular
disease prevention in under-40 year-olds. In this pa-
per we discuss present knowledge regarding the
clinical course of acute coronary syndromes and
prognosis in patients below the age of 45.
The main cause of MI in young people is coro-
nary atherosclerosis (about 80% of cases), usually
one vessel disease [5]. Atherosclerotic process
begins at birth and significant lesions in coronary
arteries may be present as early as age 25 or 30 [2, 6].
After the age of 40, the first symptoms of exercise-
induced ischaemia are not uncommon. The reasons
for such rapid progression of atherosclerosis, caus-
ing MI at the age of about 40, are still being inves-
tigated. Beręsewicz et al. [7] indicate that the proc-
ess may even begin in foetus. The authors empha-
size that although the dynamics of atherosclerosis
are determined by classic risk factors, the suscep-
tibility to proatherosclerotic factors is programmed
by external influences during intrauterine growth,
for example mother’s hypercholesterolaemia. Re-
cent studies prove that environmental influence on
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genotype may promote the development of coro-
nary artery disease in young age.
There is no doubt that the presence of classic
risk factors is strongly causatively related to athero-
sclerosis and myocardial infarction in young people.
Based on post-mortem examinations of children and
young adults, the progression and range of athero-
sclerosis in this population is proven to have strong
connection to a number of risk factors. In more than
90% of 40 year-old patients having a first myocar-
dial infarction, more than one risk factor is found
(Table 1) [6, 8].
Most recent studies have identified smoking as
the strongest risk factor in both men and women
under 40 suffering from acute coronary syndrome [9].
Religa et al. [10] found that of 100 women admitted
with first myocardial infarction, 45% were smokers,
while in the subset of patients below 45 years of age,
the figure was 95%. In the epidemiological studies
WOBASZ and NATPOL PLUS, in the general popu-
lation about 25% women and 42% men were smok-
ers, many of them aged 18–31 [11, 12].
Dyslipidemia occurs in about 29% of patients
with myocardial infarction below the age of 40. In
the Polish population hypercholesterolemia affects
23% of women and 25% of men while 17% of peo-
ple aged 18–29 have hypertriglicerydemia [12].
Premature coronary artery disease is most common
in patients with familial hypercholesterolemia, less
often in familial mixed dyslipidemia. The results of
many studies indicate significantly higher levels of
triglicerydes and total cholesterol and lower con-
centration of HDL-cholesterol (especially HDL2) in
patients with coronary artery disease under 40,
compared with those in whom the disease occurred
after 60 [13, 14]. The GRIPS study [15] of over 5,000
patients confirms that a high level of LDL-choles-
terol is a significant risk factor of myocardial inf-
arction in men under 45. The elevation of total cho-
lesterol and LDL-cholesterol concentrations is
strongly connected to the increase of ischemic heart
disease risk. In patients with hypertriglicerydemia
the highest risk of ischemic heart disease occurs
when the triglicerydes level is moderately in-
creased, but often accompanied by severe increase
of highly atherogenic VLDL.
Premature ischemic heart disease in first-de-
gree relatives is recognized as an independent risk
factor for this disease under the age of 40 [14]. This
long-known relationship [14, 16], and ethnic dif-
ferences in susceptibility to atherosclerosis, are be-
ing explained as DNA structure research continues.
Many proatherogenic genetic factors were discovered.
Apolipoprotein E is a good example of gene poli-
morphism modifying atherosclerotic process [17].
It comes in three main variants: E2, E3 and E4.
Large metaanalysis conducted in 2004 identified the
presence of allel E4 as an important risk factor for
atherosclerosis and ischemic heart disease.
Arterial hypertension is less common in young
patients [8]. Recently in Poland arterial hyperten-
sion was diagnosed in 5% of the 18–31 year-old
population; it affects 12% of young patients after
myocardial infarction [18].
Type 2 diabetes mellitus affects only 3–5% of
patients after myocardial infarction under the age
of 45 [18].
On the other hand, obesity is quite common in
this group of young adults. Between 35% and 58%
of patients after myocardial infarction under the age
of 45 are obese [18]. Obesity doubles the risk of
myocardial infarction in men and increases the risk
in women by 2.5 times. The molecular mechanism
explaining the pathogenesis of many cardiovascu-
lar diseases in obese people is unclear. Disorder of
the intracellular lipid metabolism is an important
issue in metabolic syndrome pathogenesis. Exces-
sive accumulation of triglicerydes impairs the func-
tion of cardiomyocytes, liver and pancreas.
The risk factors presented above concern
mainly myocardial infarction caused by coronary
artery atherosclerosis. Still, in the population young-
er than 40 years, myocardial infarction in patients
without coronary artery stenosis is not uncommon.
The main causes of those are: coronary artery em-
bolism (5% of cases), thrombosis (5%), anomaly (4%)
and vessel inflammation or spasm [19].
Cocaine and amphetamine use is a factor in an
increasing number of MIs. Dangerous complications
of such ‘hard’ drugs are more frequently being de-
scribed in the literature. Myocardial infarction af-
ter cocaine abuse was first reported in 1982 [20].
This drug causes heart rate and systolic blood
pressure increase with artery spasm followed by
Table 1. Risk factors of myocardial infarction and
their prevalence among Poles aged 18–30.
Risk factor Prevalence
Smoking Women: 23%; men: 41%
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reduced coronary flow, which results in imbalance
between oxygen consumption and supply. Increase
in thrombocytes aggregation stimulated by cocaine
may be a direct factor triggering coronary artery
thrombosis. Another factor possibly leading to myo-
cardial infarction after cocaine or amphetamine use
is the blocking of sodium channels and the presy-
naptic part of the neuron, resulting in excessive re-
lease of neurotransmitters like norepinephrine and
dopamine. Authors describing MI after intravenous
drug injection emphasize the presence of unchanged
coronary arteries in coronary angiography conduct-
ed after acute phase [21, 22]. On the other hand, tran-
sient impairment of blood flow was observed in the
case of a young woman with MI after amphetamine
use, in whom coronary angiography was performed
within several hours of the onset of chest pain [23].
Moreover, cocaine may cause direct toxic lesion of
myocardium, resulting in focal necrosis [24]. Infarc-
tions in marihuana smokers are also reported [25].
There are reports regarding the possibility of
myocardial infarction after overdosing on medi-
cines. The case of a 29 year-old male was described,
who after attempting suicide by taking a high dose
(50 times greater than the therapeutic one) of ri-
fampicine, was observed to have typical severe
stenocardia, ST-segment elevation, systolic dys-
function with major decrease of left ventricular ejec-
tion fraction as well as elevated levels of markers
of myocardial necrosis. In coronary angiography no
plaques were found. It is believed that toxic influ-
ence on endothelium may be the cause of drug-in-
duced acute coronary syndromes [26].
Myocardial infarctions caused by coagulation
disorders constitute 5% of all cases. An imbalance
between coagulation and fibrynolysis may increase
the risk of thrombus forming in the unchanged ar-
tery. Blood platelets play an important role in the
development of thrombosis. Weiss et al. [27] em-
phasize the importance of many polimorphisms of
platelet receptors (GP Ib and GP IIb/IIIa). Patients
with polimorphism have a six times greater risk of
coronary artery thrombosis. Also, an increase in
thrombocytes aggregation in response to ADP is
more expressed in young patients after myocardial
infarction than in the healthy control group. A re-
duced activity of plasminogen activator inhibitor
was reported in many young individuals with a his-
tory of MI [28]. Polimorphism of gene Bc11 (cod-
ing beta chain of fibrinogen), related to elevated fi-
brinogen levels, was proved to be more common in
young patients after myocardial infarction. Tanis et
al. [29] reported a 12 times greater risk of MI in
smoking women with prothrombotic mutation than
in the control group and a doubled risk in smoking
women with factor V Leiden mutation.
Antiphospholipid syndrome is a rare back-
ground of MI in young women. In this disease
arterial thromboembolism is likely, which may
result in infarction. Antiphospholipid syndrome
manifests as venous thromboembolism, thrombo-
sis in arteries (with tendency to locate in cerebral
circulation), moderate thrombocytopenia and
obstetric complications, mainly habitual miscar-
riages. The mechanism of thrombotic complica-
tions is multi-factorial and not entirely clear.
Endothelium damage, excessive platelet activation
and imbalance between coagulation and fibrynolysis
may play important roles [30].
There are also reports about acute myocardi-
tis with a severe clinical course and clinical symp-
toms of acute myocardial infarction [31]. In myo-
carditis, the symptoms mimicking acute MI appear
a few days after the onset of the disease when body
temperature decreases. Jarisch-Herxheimer reac-
tion is connected with endotoxin release and accom-
panied by elevation of cytokines levels [32].
In rare cases of MI in young patients, a coro-
nary artery anomaly is diagnosed [33, 34].
Myocardial bridge may cause acute coronary
syndrome. This structure is found during 15 to 85%
of autopsies, but is seldom diagnosed in coronary
angiography: only in 0.5 to 2.5% of cases [35–38].
In conclusion, we must emphasize that most
(as many as 80%) of young patients with MI have
typical atherosclerotic coronary stenosis, usually
one vessel disease [5, 13, 39]. Klein et al. [40] found
three vessel disease in 19% of young individuals
with myocardial infarction, although multivessel
lesions were present mainly in those who had sev-
eral risk factors, especially diabetes.
What are the differences in the clinical course
of ischemic heart disease in young people? What are
the most characteristic features in this population?
Young patients with coronary artery disease
usually have no concomitant disorders. After myo-
cardial infarction they have higher left ventricular
ejection fraction and lower levels of pro-brain natriu-
retic peptide than older groups [41].
The results of GISSI study [18] indicate that
younger age is an independent prognostic factor of
a favorable clinical course in myocardial infarction.
It is estimated that increased risk of recurrent cor-
onary events concerns only 5% of patients with MI
under the age of 40. Nevertheless, the problem of
sudden death risk remains, because according to
some authors it is significantly higher than in the
older group [41, 42].
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It should be highlighted that patients younger
than 45 years, in whom primary percutaneous trans-
luminal coronary angioplasty was performed, espe-
cially benefit from a good prognosis in the early
period of hospitalization as well as in long-term
follow-up.
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